Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof

a caspase activator and analog technology, applied in the field of substituted 4hchromenes and analogs, can solve problems such as bone marrow toxicity, and achieve the effect of treating, preventing or ameliorating neoplasia and cancer

Inactive Publication Date: 2006-02-16
CYTOVIA INC
View PDF10 Cites 13 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Thus, a drug like 6-mercaptopurine can cause bone marrow toxicity while remaining ineffective for a slow growing tumor.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
  • Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
  • Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1

2-Amino-3-cyano-7-hydroxy-4-(3-bromo-4,5-dimethoxyphenyl)-4H-chromene

[0369] To a mixture of 3,4-dimethoxy-5-bromobenzylidenemalononitrile (293 mg, 1 mmol) and resorcinol (110 mg, 1 mmol) in ethanol (2 mL) was added piperidine (0.1 mL, 1 mmol). The mixture was refluxed for 2 h. The solvent was evaporated, the residue was purified by chromatography on silica gel with EtOAc and hexane (1:2) as eluant, yielding 240 mg (59.5%) of the title compound. 1H NMR (DMSO-d6): 9.77 (brs, 1H), 6.96-6.86 (m, 5H), 6.52 (d, J=8.1, 1H), 6.41 (s, 1H), 4.65 (s, 1H), 3.80 (s, 3H), 3.70(s, 3H).

example 2a

2-Amino-3-cyano-7-ethylamino-4-(3-bromo-4,5-dimethoxyphenyl)-4H-chromene

[0370] To a mixture of 5-bromoveratraldehyde (245 mg, 1 mmol) and malononitrile (66 mg, 1 mmol) in ethanol (2 mL) was added piperidine (0.1 ml, 1 mmol) and 3-ethylaminephenol (140 mg, 1 mmol). The mixture was stirred at room temperature overnight. The solvent was evaporated, the residue was purified by chromatography on silica gel with EtOAc and hexane (1:2) as eluant, yielding (330 mg, 76.7%) title compound. 1H NMR (CDCl3): 6.88 (d, J=0.9 Hz, 1H), 6.71 (d, J=8.4 Hz, 2H), 6.32 (dd, J=2.1 Hz, 1H), 6.19 (d, J=2.1 Hz, 1H), 4.59 (s, 2H), 4.54 (s, 1H), 3.83 (d, J=0.6 Hz, 3H), 3.82 (d, J=0.9 Hz, 1H), 3.68 (brs, 1H), 3.12 (q, J=7.2 Hz, 2H), 1.28-1.23 (m, 3H).

[0371] The following compounds were prepared by a procedure similar to that described in Example 2A.

example 2b

2-Amino-3-cyano-7-hydroxy-4-(3-cyanophenyl)-4H-chromene

[0372]1H NMR (DMSO-d6): 7.70-7.65 (m, 2H), 7.55-7.47 (m, 2H), 6.99 (brs, 2H), 6.79 (d, J=8.9 Hz, 1H), 6.48 (dd, J=2.5, 8.4 Hz, 1H), 6.40 (d, J=2.5 Hz, 1H), 4.76 (s, 1H) ppm.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
Login to view more

Abstract

The present invention is directed to substituted 4H-chromenes and analogs thereof, represented by the general Formula I: wherein R1-R5, A, Y and Z are defined herein. The present invention also relates to the discovery that compounds having Formula I are activators of caspases and inducers of apoptosis. Therefore, the activators of caspases and inducers of apoptosis of this invention can be used to induce cell death in a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS [0001] This application claims priority benefit under 35 U.S.C. § 119(e) of U.S. Provisional Application No. 60 / 290,997, filed May 16, 2001, the contents of which are entirely incorporated by reference herein.BACKGROUND OF THE INVENTION [0002] 1. Field of the Invention [0003] This invention is in the field of medicinal chemistry. In particular, the invention relates to substituted 4H-chromenes and analogs, and the discovery that these compounds are activators of caspases and inducers of apoptosis. The invention also relates to the use of these compounds as therapeutically effective anti-cancer agents. [0004] 2. Related Art [0005] Organisms eliminate unwanted cells by a process variously known as regulated cell death, programmed cell death or apoptosis. Such cell death occurs as a normal aspect of animal development, as well as in tissue homeostasis and aging (Glucksmann, A., Biol. Rev. Cambridge Philos. Soc. 26:59-86 (1951); Glucksmann, A., Ar...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/407A61K31/353A61K31/35A61K31/352A61K31/38A61K31/382A61K31/40A61K31/4025A61K31/415A61K31/4188A61K31/44A61K31/453A61K31/47A61K31/495A61K31/496A61K31/497A61K31/4985A61K31/50A61K31/505A61K31/506A61K31/535A61K31/5377A61K33/24A61K45/06A61P1/00A61P17/00A61P17/06A61P19/02A61P29/00A61P35/00A61P37/02A61P43/00C07D215/54C07D311/58C07D311/64C07D335/06C07D405/04C07D491/04C07D491/052C07D493/04C07D495/04
CPCA61K31/35A61K31/353C07D495/04C07D493/04C07D491/04C07D405/04C07D335/06C07D311/64C07D311/58C07D215/54A61K45/06A61K33/24A61K31/535A61K31/505A61K31/50A61K31/497A61K31/495A61K31/47A61K31/44A61K31/415A61K31/407A61K31/40A61K31/38A61K2300/00A61P1/00A61P17/00A61P17/06A61P19/02A61P29/00A61P35/00A61P35/02A61P37/02A61P43/00
Inventor CAI, SUI XIONGZHANG, HONGJIANG, SONGCHUNSTORER, RICHARD
Owner CYTOVIA INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products